Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

The renin-angiotensin system in the breast and breast cancer.

Vinson GP, Barker S, Puddefoot JR.

Endocr Relat Cancer. 2012 Feb 13;19(1):R1-19. doi: 10.1530/ERC-11-0335. Print 2012 Feb. Review.

PMID:
22180497
2.

Changes in angiotensin II type 1 receptor signalling pathways evoked by a monoclonal antibody raised to the N-terminus.

Xiao F, Puddefoot JR, Barker S, Vinson GP.

J Endocrinol. 2008 Apr;197(1):25-33. doi: 10.1677/JOE-07-0498.

PMID:
18372229
3.

Anti-cancer actions of a recombinant antibody (R6313/G2) against the angiotensin II AT1 receptor.

Redondo-Müller MA, Stevanovic-Walker M, Barker S, Puddefoot JR, Vinson GP.

Endocr Relat Cancer. 2008 Mar;15(1):277-88. doi: 10.1677/ERC-07-0068.

PMID:
18310294
4.

Trilostane in advanced breast cancer.

Puddefoot JR, Barker S, Vinson GP.

Expert Opin Pharmacother. 2006 Dec;7(17):2413-9. Review.

PMID:
17109615
5.

The role of angiotensin II in the regulation of breast cancer cell adhesion and invasion.

Puddefoot JR, Udeozo UK, Barker S, Vinson GP.

Endocr Relat Cancer. 2006 Sep;13(3):895-903.

PMID:
16954438
6.

Regulation of hepatic steroid receptors and enzymes by the 3beta-hydroxysteroid dehydrogenase inhibitor trilostane.

Malouitre SD, Barker S, Puddefoot JR, Jalili J, Glover HR, Vinson GP.

J Steroid Biochem Mol Biol. 2006 Oct;101(2-3):97-105. Epub 2006 Aug 8.

PMID:
16893643
7.

Comparison of effects of 4-hydroxy tamoxifen and trilostane on oestrogen-regulated gene expression in MCF-7 cells: up-regulation of oestrogen receptor beta.

Barker S, Malouitre SD, Glover HR, Puddefoot JR, Vinson GP.

J Steroid Biochem Mol Biol. 2006 Aug;100(4-5):141-51. Epub 2006 Jun 27.

PMID:
16806905
8.

Localisation of renin-angiotensin system (RAS) components in breast.

Tahmasebi M, Barker S, Puddefoot JR, Vinson GP.

Br J Cancer. 2006 Jul 3;95(1):67-74. Epub 2006 Jun 6.

9.

Synthesis and secretion of angiotensin II by the prostate gland in vitro.

O'Mahony OA, Barker S, Puddefoot JR, Vinson GP.

Endocrinology. 2005 Jan;146(1):392-8. Epub 2004 Sep 24.

PMID:
15448113
10.

Mechanism for aldosterone potentiation of angiotensin II-stimulated rat arterial smooth muscle cell proliferation.

Xiao F, Puddefoot JR, Barker S, Vinson GP.

Hypertension. 2004 Sep;44(3):340-5. Epub 2004 Aug 9.

PMID:
15302841
11.

Integrin beta1-mediated invasion of human breast cancer cells: an ex vivo assay for invasiveness.

Berry MG, Goode AW, Puddefoot JR, Vinson GP, Carpenter R.

Breast Cancer. 2003;10(3):214-9.

PMID:
12955033
12.

Effect of angiotensin II on ion transport across human Fallopian tube epithelial cells in vitro.

Mahmood T, Djahanbakhch O, Burleigh DE, Puddefoot JR, O'Mahony OA, Vinson GP.

Reproduction. 2002 Oct;124(4):573-9.

PMID:
12361476
13.

Non-competitive steroid inhibition of oestrogen receptor functions.

Puddefoot JR, Barker S, Glover HR, Malouitre SD, Vinson GP.

Int J Cancer. 2002 Sep 1;101(1):17-22.

14.

The effect of cAMP on ion transport in Fallopian tube epithelial cells in vitro.

Mahmood T, Djahanbakhch O, Burleigh D, Puddefoot JR, Vinson GP.

Mol Hum Reprod. 2001 Oct;7(10):957-61.

PMID:
11574664
15.

Angiotensin II in human seminal fluid.

O'Mahony OA, Djahanbahkch O, Mahmood T, Puddefoot JR, Vinson GP.

Hum Reprod. 2000 Jun;15(6):1345-9.

PMID:
10831566
16.

Aldosterone mediates angiotensin II-stimulated rat vascular smooth muscle cell proliferation.

Xiao F, Puddefoot JR, Vinson GP.

J Endocrinol. 2000 May;165(2):533-6.

PMID:
10810318
17.

Integrin beta1 upregulation in MCF-7 breast cancer cells by angiotensin II.

Berry MG, Goode AW, Puddefoot JR, Vinson GP, Carpenter R.

Eur J Surg Oncol. 2000 Feb;26(1):25-9.

PMID:
10718175
18.

The expression of renin and the formation of angiotensin II in bovine aortic endothelial cells.

Xiao F, Puddefoot JR, Vinson GP.

J Endocrinol. 2000 Feb;164(2):207-14.

PMID:
10657856
19.

Renin-angiotensin systems and reproduction.

Vinson GP, Saridogan E, Puddefoot JR, O'Mahony OA, Mahmood T, Djahanbakhch O.

Gynecol Endocrinol. 1999 Feb;13(1):56-70. Review. No abstract available.

PMID:
10368799
20.

The tissue renin-angiotensin system in human pancreas.

Tahmasebi M, Puddefoot JR, Inwang ER, Vinson GP.

J Endocrinol. 1999 May;161(2):317-22.

PMID:
10320830
21.

Actions of vasoactive intestinal peptide on the rat adrenal zona glomerulosa.

Hinson JP, Puddefoot JR, Kapas S.

J Endocrinol. 1999 Apr;161(1):51-7.

PMID:
10194528
22.

Transcription of the prorenin gene in normal and diseased breast.

Tahmasebi M, Puddefoot JR, Inwang ER, Goode AW, Carpenter R, Vinson GP.

Eur J Cancer. 1998 Oct;34(11):1777-82.

PMID:
9893668
23.

Pref-1, SF-1 and adrenocortical zonation.

Raza FS, Puddefoot JR, Vinson GP.

Endocr Res. 1998 Aug-Nov;24(3-4):977-81.

PMID:
9888610
24.

Adrenocortical zonation and the adrenal renin-angiotensin system.

Vinson GP, Ho MM, Puddefoot JR.

Endocr Res. 1998 Aug-Nov;24(3-4):677-86.

PMID:
9888559
25.

Short circuit current in rat adrenal capsule/glomerulosa.

Firth KM, Puddefoot JR, Vinson GP.

Endocr Res. 1998 Aug-Nov;24(3-4):439-42.

PMID:
9888522
26.

MAP Kinase in the rat adrenal gland.

McNeill H, Puddefoot JR, Vinson GP.

Endocr Res. 1998 Aug-Nov;24(3-4):373-80.

PMID:
9888509
27.

The role of the tissue renin-angiotensin system in the response of the rat adrenal to exogenous angiotensin II.

Vinson GP, Teja R, Ho MM, Hinson JP, Puddefoot JR.

J Endocrinol. 1998 Aug;158(2):153-9.

PMID:
9771458
28.

Tissue renin-angiotensin systems and reproduction.

Vinson GP, Saridogan E, Puddefoot JR, Djahanbakhch O.

Hum Reprod. 1997 Apr;12(4):651-62. Review.

PMID:
9159419
29.

Endothelin-1 acts through ETA receptors to stimulate aldosterone secretion by the rat adrenal gland.

Hinson JP, Cameron LA, Puddefoot JR, Kapas S.

Biochem Soc Trans. 1997 Feb;25(1):116S. No abstract available.

PMID:
9057014
30.

Angiotensin II type 1 receptor expression in human breast tissues.

Inwang ER, Puddefoot JR, Brown CL, Goode AW, Marsigliante S, Ho MM, Payne JG, Vinson GP.

Br J Cancer. 1997;75(9):1279-83. Erratum in: Br J Cancer 1997;76(6):827.

31.

Altered cell-matrix contact: a prerequisite for breast cancer metastasis?

Gui GP, Puddefoot JR, Vinson GP, Wells CA, Carpenter R.

Br J Cancer. 1997;75(5):623-33.

32.

Angiotensin II stimulates sperm motility.

Vinson GP, Mehta J, Evans S, Matthews S, Puddefoot JR, Saridogan E, Holt WV, Djahanbakhch O.

Regul Pept. 1996 Dec 3;67(2):131-5.

PMID:
8958584
33.
34.

Role of the tissue renin-angiotensin system in the response of the rat adrenal to exogenous angiotensin II.

Vinson GP, Teja R, Ho MM, Hinson JP, Puddefoot JR.

Endocr Res. 1996 Nov;22(4):589-93.

PMID:
8969916
35.

Type 1 angiotensin II receptors in human endometrium.

Saridogan E, Djahanbakhch O, Puddefoot JR, Demetroulis C, Dawda R, Hall AJ, Vinson GP.

Mol Hum Reprod. 1996 Sep;2(9):659-64.

PMID:
9239679
36.

Angiotensin II receptors and angiotensin II stimulation of ciliary activity in human fallopian tube.

Saridogan E, Djahanbakhch O, Puddefoot JR, Demetroulis C, Collingwood K, Mehta JG, Vinson GP.

J Clin Endocrinol Metab. 1996 Jul;81(7):2719-25.

PMID:
8675601
37.

In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix.

Gui GP, Puddefoot JR, Vinson GP, Wells CA, Carpenter R.

Br J Surg. 1995 Sep;82(9):1192-6.

PMID:
7551993
38.

Modulation of very late activation-2 laminin receptor function in breast cancer metastasis.

Gui GP, Puddefoot JR, Vinson GP, Wells CA, Carpenter R.

Surgery. 1995 Aug;118(2):245-50.

PMID:
7638740
39.

Multiple isoforms of the oestrogen receptor in endometrial cancer.

Marsigliante S, Muscella A, Ciardo V, Puddefoot JR, Leo G, Vinson GP, Storelli C.

J Mol Endocrinol. 1995 Jun;14(3):365-74.

PMID:
7669226
40.

Zonal biochemical and morphological characteristics in BPH.

Feneley MR, Puddefoot JR, Xia S, Sowter C, Slavin G, Kirby RS, Vinson GP.

Br J Urol. 1995 May;75(5):608-13.

PMID:
7542130
41.

The distribution of angiotensin II type 1 receptors, and the tissue renin-angiotensin systems.

Vinson GP, Ho MM, Puddefoot JR.

Mol Med Today. 1995 Apr;1(1):35-9. Review.

PMID:
9415136
42.

Type 1 angiotensin II receptors in rat and human sperm.

Vinson GP, Puddefoot JR, Ho MM, Barker S, Mehta J, Saridogan E, Djahanbakhch O.

J Endocrinol. 1995 Feb;144(2):369-78.

PMID:
7706989
44.

Internalisation of the type I angiotensin II receptor (AT1) and angiotensin II function in the rat adrenal zona glomerulosa cell.

Vinson GP, Ho MM, Puddefoot JR, Teja R, Barker S, Kapas S, Hinson JP.

Endocr Res. 1995 Feb-May;21(1-2):211-7.

PMID:
7588383
45.

Zonation, paracrine function and aldosterone secretion in the rat adrenal cortex.

Vinson GP, Teja R, Ho MM, Puddefoot JR, Hinson JP.

Endocr Res. 1995 Feb-May;21(1-2):1-12.

PMID:
7588369
46.

Integrin expression in primary breast cancer and its relation to axillary nodal status.

Gui GP, Wells CA, Browne PD, Yeomans P, Jordan S, Puddefoot JR, Vinson GP, Carpenter R.

Surgery. 1995 Jan;117(1):102-8.

PMID:
7809822
49.

Internalisation of the type I angiotensin II receptor (AT1) and angiotensin II function in the rat adrenal zona glomerulosa cell.

Vinson GP, Ho MM, Puddefoot JR, Teja R, Barker S.

J Endocrinol. 1994 May;141(2):R5-9.

PMID:
8046288
50.

A monoclonal antibody to a conserved sequence in the extracellular domain recognizes the angiotensin II AT1 receptor in mammalian target tissues.

Barker S, Marchant W, Ho MM, Puddefoot JR, Hinson JP, Clark AJ, Vinson GP.

J Mol Endocrinol. 1993 Oct;11(2):241-5.

PMID:
7507680

Supplemental Content

Loading ...
Support Center